Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
World Journal of Gastroenterology, cilt.28, sa.4, ss.500-501, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 28 Sayı: 4
- Basım Tarihi: 2022
- Doi Numarası: 10.3748/wjg.v28.i4.500
- Dergi Adı: World Journal of Gastroenterology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.500-501
- Anahtar Kelimeler: Colorectal cancer, Carbohydrate antigen 19-9, Liver metastasis of colorectal cancer, Synchronous liver metastasis, Chemotherapy, Metastatic colorectal cancer
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Evaluation of response to chemotherapy in colorectal cancer patients with synchronous liver metastases is important in terms of treatment management. In this Letter to the Editor, several issues in the article are discussed. For the comparison of carbohydrate antigen 19-9 (CA19-9) values referenced in the study, the patient group was not matched for cancer stage. Therefore, it may be more appropriate to select and compare CA19-9 values in patients with same-stage cancer.